Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Screening Europe

Jani Saarela's Biography



Jani Saarela, Operational Manager, Screening Unit, Institute for Molecular Medicine

Jani Saarela, Ph.D., Senior researcher. Dr Saarela was educated at University of Helsinki, where he received his Ph.D. in the Medical Faculty in 2004. Before joining FIMM in 2010, he worked at National Institute of Health and Welfare, Helsinki, and the Medical University of Vienna. He is currently operational manager of High Throughput Biomedicine unit in FIMM at University of Helsinki, and he is actively using and developing the DSRT platform in addition to developing QC and analysis tools for DSRT.

Jani Saarela Image

Drug Sensitivity and Resistance Testing Platform for Personalized Medicine at the Institute for Molecular Medicine Finland (FIMM)

Wednesday, 18 February 2015 at 09:00

Add to Calendar ▼2015-02-18 09:00:002015-02-18 10:00:00Europe/LondonDrug Sensitivity and Resistance Testing Platform for Personalized Medicine at the Institute for Molecular Medicine Finland (FIMM)Screening Europe in Berlin, GermanyBerlin, GermanySELECTBIOenquiries@selectbiosciences.com

At FIMM, a drug sensitivity and resistance platform is used for ex vivo drug testing of primary cancer cells as well as cancer cell lines. Application of the platform to AML patient samples has uncovered taxonomic drug-response subtypes and individualised therapy based on DSRT has resulted in several clinical responses.


Add to Calendar ▼2015-02-17 00:00:002015-02-18 00:00:00Europe/LondonScreening EuropeScreening Europe in Berlin, GermanyBerlin, GermanySELECTBIOenquiries@selectbiosciences.com